IBD Anti-TNF Failure Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About IBD Anti-TNF Failure
Inflammatory Bowel Disease (IBD) can be challenging, especially when anti-TNF therapies, a common treatment, stop working effectively. This 'anti-TNF failure' means finding new, often costly, medications. TheDrugClub helps you access these vital prescriptions at a fraction of the price, ensuring your health remains a top priority without added financial strain.
Inflammatory Bowel Disease (IBD), encompassing conditions like Crohn's disease and ulcerative colitis, involves chronic inflammation of the digestive tract. For many patients, anti-TNF medications such as infliximab (Remicade) or adalimumab (Humira) are highly effective in managing symptoms and achieving remission. These biologics work by blocking tumor necrosis factor-alpha (TNF-α), a protein that promotes inflammation.
However, for a significant number of individuals, these treatments may eventually lose their effectiveness, or they might not work from the outset. This is known as 'anti-TNF failure.' When this happens, it can be incredibly disheartening, as it means the disease is still active, causing symptoms like abdominal pain, diarrhea, fatigue, and weight loss, and potentially leading to complications.
When anti-TNF therapies are no longer an option, your healthcare provider will explore alternative treatment strategies. These often include other classes of advanced biologics, such as
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.